Cardiovascular diseases. Abnormal results of cardiovascular function studies
Conditions
Interventions
Intervention 1: Intervention group: he intervention group will be formed in order to create group coordination in a group approved by all members. Group meetings will be held in groups of 40 people. I
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Suffering from one of the types of cardiovascular diseases Being able to speak Persian Interest in the participation
Exclusion criteria
Exclusion criteria: Suffering from psychiatric disorders Participation in other similar interventions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life score. Timepoint: Measuring the quality of life score at the beginning of the study, 10 weeks later, 22 weeks later. Method of measurement: The 36-Item Short Form Health Survey (SF-36).;Self-efficacy. Timepoint: Measuring the quality of life score at the beginning of the study, 10 weeks later, 22 weeks later. Method of measurement: Sullivan’s cardiac self-efficacy scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadamin Jandaghian-Bidgoli
Shahid Beheshti University of Medical Sciences
Outcome results
None listed